Question 1 · Medium
Blood cultures from a woman in a surgical intensive care unit grow a yeast after three weeks of broad-spectrum antibiotics, total parenteral nutrition and a femoral central line. The laboratory reports a Candida species that its biochemical panel could not name with confidence, resistant to fluconazole on testing, and the same yeast has been recovered from the bed rails and blood pressure cuff of the patient in the adjacent bay. She remains febrile at 38.9 degrees C on meropenem, with no other focus of infection found. Which organism and which single infection-control action fit best?
- ACandida glabrata; airborne precautions
- BCandida auris; contact precautions with single-room isolation
- CCandida albicans; standard precautions only
- DCandida tropicalis; cohorting of patients without any change in cleaning
Show answerHide answer
Answer: B · Candida auris; contact precautions with single-room isolation
Candida auris is commonly misidentified by conventional systems, is often fluconazole-resistant and persists on skin and surfaces, so it spreads between patients in critical care units. Confirmed or suspected cases need single-room isolation with contact precautions, dedicated equipment, chlorine or hydrogen-peroxide-based cleaning and screening of contacts. Key point: Candida auris: misidentified, often fluconazole-resistant, persists on surfaces; isolate with contact precautions.
- A: C. glabrata is fluconazole-resistant but is not transmitted by air.
- C: C. albicans is easily identified and usually fluconazole-susceptible; it does not spread this way.
- D: Cohorting without changed cleaning fails because this yeast survives on surfaces.